Home › Hypertrophic Cardiomyopathy › Illinois
Hypertrophic Cardiomyopathy clinical trials in Illinois
4 studies for Hypertrophic Cardiomyopathy are looking for participants at sites in Illinois.
Cities in Illinois
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- University of Chicago Dept of Medicine, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705Study of the Progression of Chronic Cardiovascular Conditions
- Prolaio, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07420907A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Chicago
- Imbria Investigational Site, Oak Lawn
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT07023614HCMR Re-Imaging Study
- Northwestern, Evanston
RecruitingObservational study
Ages 18 to 65 · All sexes · Updated Mar 18, 2026 · NCT07054073From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.